DK101888D0 - Immunmodulerende midler og anvendelse af disse - Google Patents
Immunmodulerende midler og anvendelse af disseInfo
- Publication number
- DK101888D0 DK101888D0 DK101888A DK101888A DK101888D0 DK 101888 D0 DK101888 D0 DK 101888D0 DK 101888 A DK101888 A DK 101888A DK 101888 A DK101888 A DK 101888A DK 101888 D0 DK101888 D0 DK 101888D0
- Authority
- DK
- Denmark
- Prior art keywords
- region
- compositions
- cells
- relation
- application
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88013486A | 1986-06-30 | 1986-06-30 | |
US92428686A | 1986-10-29 | 1986-10-29 | |
US1734387A | 1987-02-20 | 1987-02-20 | |
PCT/US1987/001532 WO1988000057A1 (en) | 1986-06-30 | 1987-06-26 | Immunomodulating compositions and their use |
Publications (2)
Publication Number | Publication Date |
---|---|
DK101888D0 true DK101888D0 (da) | 1988-02-26 |
DK101888A DK101888A (da) | 1988-04-26 |
Family
ID=27360777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK101888A DK101888A (da) | 1986-06-30 | 1988-02-26 | Immunmodulerende midler og anvendelse af disse |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0271577B1 (da) |
JP (2) | JP2633881B2 (da) |
KR (1) | KR880701108A (da) |
AT (1) | ATE128627T1 (da) |
AU (1) | AU603131B2 (da) |
DE (1) | DE3751553T2 (da) |
DK (1) | DK101888A (da) |
WO (1) | WO1988000057A1 (da) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5843445A (en) * | 1987-06-24 | 1998-12-01 | Autoimmune, Inc. | Method of treating rheumatoid arthritis with type II collagen |
US5645820A (en) * | 1987-06-24 | 1997-07-08 | Autoimmune, Inc. | Treatment of autoimmune diseases by aerosol administration of autoantigens |
JP2512796B2 (ja) † | 1987-06-24 | 1996-07-03 | オートイミュン・インコーポレイテッド | 自己抗原の経口投与による自己免疫疾患の治療法 |
US5869054A (en) * | 1987-06-24 | 1999-02-09 | Autoimmune Inc. | Treatment of multiple sclerosis by oral administration of autoantigens |
US5849298A (en) * | 1987-06-24 | 1998-12-15 | Autoimmune Inc. | Treatment of multiple sclerosis by oral administration of bovine myelin |
US6645504B1 (en) | 1987-06-24 | 2003-11-11 | Autoimmune Inc. | Bystander suppression of type I diabetes by oral administration of glucagon |
US5641474A (en) * | 1987-06-24 | 1997-06-24 | Autoimmune, Inc. | Prevention of autoimmune diseases by aerosol administration of autoantigens |
US6039947A (en) * | 1987-06-24 | 2000-03-21 | Autoimmune, Inc. | Peptides derived from immunodominant epitopes of myelin basic protein |
CA1335792C (en) * | 1987-08-18 | 1995-06-06 | Chaim O. Jacob | Method and dosage form using an antagonist to gamma interferon to control mhc-associated autoimmune disease |
JPH03504493A (ja) * | 1988-02-12 | 1991-10-03 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 細胞性免疫の発生及び操作のための合成ペプチドの使用 |
EP0420913B1 (en) * | 1988-06-14 | 1995-11-15 | Cell Med, Inc. | Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same |
US5260422A (en) * | 1988-06-23 | 1993-11-09 | Anergen, Inc. | MHC conjugates useful in ameliorating autoimmunity |
US5194425A (en) * | 1988-06-23 | 1993-03-16 | Anergen, Inc. | Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
US6106840A (en) * | 1988-06-23 | 2000-08-22 | Anergen, Inc. | MHC conjugates useful in ameliorating autoimmunity |
US5468481A (en) * | 1988-06-23 | 1995-11-21 | Amergen, Inc. | MHC class II-peptide conjugates useful in ameliorating autoimmunity |
US5858980A (en) * | 1990-03-30 | 1999-01-12 | Autoimmune, Inc. | Peptide fragments of myelin basic protein |
CA2092905C (en) * | 1990-10-15 | 2002-01-08 | Howard L. Weiner | Treatment of autoimmune diseases by oral administration of autoantigens |
US7090982B2 (en) | 1991-10-22 | 2006-08-15 | The Governors Of The University Of Alberta | Methods of predicting therapeutic efficacy of treatment of a multiple sclerosis patient |
US6252040B1 (en) | 1991-10-22 | 2001-06-26 | The Governors Of The University Of Alberta | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
US6379670B1 (en) | 1994-11-18 | 2002-04-30 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
US6251396B1 (en) | 1994-11-18 | 2001-06-26 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
US5856446A (en) * | 1995-07-07 | 1999-01-05 | Autoimmune Inc. | Method of treating rheumatoid arthritis with low dose type II collagen |
DE69733343D1 (de) | 1996-03-21 | 2005-06-30 | Circassia Ltd | Kryptische peptide und verfahren zu ihrer identifizierung |
DE102011004335A1 (de) | 2011-02-17 | 2012-08-23 | Thomas Grammel | Verfahren zur Herstellung eines Vakzins |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1979000160A1 (en) * | 1977-09-28 | 1979-04-05 | Nat Res Dev | Improvements in or relating to immunological preparations |
US4469677A (en) | 1980-02-19 | 1984-09-04 | Michael J Gabriel | Polypeptide active immunosuppressant fraction |
US4565696A (en) | 1983-08-03 | 1986-01-21 | The Regents Of The University Of California | Production of immunogens by antigen conjugation to liposomes |
US4473555A (en) | 1983-10-17 | 1984-09-25 | Syntex (U.S.A.) Inc. | Nona- and dodecapeptides for augmenting natural killer cell activity |
US4599230A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
-
1987
- 1987-06-26 KR KR1019880700237A patent/KR880701108A/ko not_active Application Discontinuation
- 1987-06-26 AT AT87905022T patent/ATE128627T1/de not_active IP Right Cessation
- 1987-06-26 EP EP87905022A patent/EP0271577B1/en not_active Revoked
- 1987-06-26 WO PCT/US1987/001532 patent/WO1988000057A1/en not_active Application Discontinuation
- 1987-06-26 AU AU77524/87A patent/AU603131B2/en not_active Ceased
- 1987-06-26 DE DE3751553T patent/DE3751553T2/de not_active Revoked
- 1987-06-26 JP JP62504476A patent/JP2633881B2/ja not_active Expired - Lifetime
-
1988
- 1988-02-26 DK DK101888A patent/DK101888A/da not_active Application Discontinuation
-
1996
- 1996-10-16 JP JP8273737A patent/JP2828960B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0271577A4 (en) | 1990-01-08 |
JP2828960B2 (ja) | 1998-11-25 |
AU7752487A (en) | 1988-01-29 |
EP0271577B1 (en) | 1995-10-04 |
DK101888A (da) | 1988-04-26 |
ATE128627T1 (de) | 1995-10-15 |
WO1988000057A1 (en) | 1988-01-14 |
JP2633881B2 (ja) | 1997-07-23 |
AU603131B2 (en) | 1990-11-08 |
DE3751553D1 (de) | 1995-11-09 |
DE3751553T2 (de) | 1996-04-25 |
JPH01500595A (ja) | 1989-03-01 |
JPH09176042A (ja) | 1997-07-08 |
KR880701108A (ko) | 1988-07-25 |
EP0271577A1 (en) | 1988-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK101888A (da) | Immunmodulerende midler og anvendelse af disse | |
DK614987A (da) | Syntetiske htlv-iii peptider, praeparater og anvendelser deraf | |
ATE127345T1 (de) | Stressproteine und verwendungen dafür. | |
DK0527760T3 (da) | Fremgangsmåder og præparater til vaccination mod HIV | |
DK0584715T3 (da) | Fremgangsmåde til isolering og dyrkning af transformerede celler og anvendelse af disse til fremstilling af antistoffer ret | |
DE68925226D1 (de) | Monoklonale Antikörper | |
DK0461177T3 (da) | Humant intra-acrosomalt spermantigen til anvendelse i en svangerskabsforebyggende vaccine | |
KR890002547A (ko) | Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드 | |
ATE145246T1 (de) | Monoklonale antikörper zur induzierung von toleranz | |
WO1996021734A3 (en) | P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods | |
DK0610335T3 (da) | Fremgangsmåder til udformning af rekombitope peptider | |
DE69738965D1 (de) | Detoxifizierung durch intramuskulär verabreichte F(ab')2 Fragmente | |
EP0303983A3 (en) | Synthetic peptides, antibodies directed against them and their use | |
Low et al. | Thymosin and other thymic hormones and their synthetic analogues | |
ATE119203T1 (de) | Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus. | |
DK0687300T3 (da) | LO-CD2a-antistof og anvendelser deraf til inhibering af T-celle-aktivering og -proliferation | |
NO883603D0 (no) | Humane monoklonale antistoffer og profylaktiske og terapeutiske midler mot infektioese sykdommer inneholdende disse som effektiv bestanddel. | |
DE3855280D1 (de) | Von mca 16-88 erkanntes antigen | |
FI950248A0 (fi) | Rokotteita monisoluisia loisia vastaan | |
FI854839A (fi) | Vaccin eller diagnostisk produkt erhaollen fraon peptid, samt daeri anvaendbar polypeptid. | |
ATE138200T1 (de) | Das von mca-28a32 erkannte antigen | |
ATE140233T1 (de) | Von gemeinsamen sequenzen von antigenen und antiidiotypischen antikörpern oder von antikörpern mit spezifizität für die zellulären rezeptoren der antigene abgeleitete immunogene und biologisch aktive peptide | |
DE69322960D1 (de) | Empfängnisverhütender impfstoff | |
PT85248A (fr) | Procede d:isolement d:un peptide presentant des proprietes antigeniques isole de la proteine 28kd de ?s.mansoni?,anticorps monoclonaux reconnaissant au moins un epitope dudit peptide et applications de celui-ci dans l:induction de la synthese d:anticorps neutralisants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |